.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07B_ViralVaccines.J07BA01_EncephalitisTickBorneIna.EncephalitisTickBorneIna .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J07B_ViralVaccines.J07BA01_EncephalitisTickBorneIna.EncephalitisTickBorneIna| name: | EncephalitisTickBorneInactivatedWholeVirus | |
| ATC code: | J07BA01 | route: | intramuscular |
| compartments: | 1 | |
| dosage: | 0.5 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | |
| other parameters in model implementation | ||
Inactivated whole virus vaccine for immunization against tick-borne encephalitis (TBE), an infectious disease caused by the tick-borne encephalitis virus. The vaccine is used prophylactically in endemic areas and is approved for use in many European and Asian countries, particularly for people at risk of tick exposure.
No pharmacokinetic parameters published for inactivated, whole virus tick-borne encephalitis vaccine; as a vaccine (biologic), absorption, distribution, and elimination follow principles typical of intramuscularly administered protein antigens in healthy adults.